Middle East and Africa Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)); Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Country
Market Introduction
Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies. Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy primary therapeutic goals include reducing symptoms, reducing symptomatic medication use, and improving allergy-related quality of life.
Get more information on this report :
Market Overview and Dynamics
The Middle East & Africa Allergy immunotherapies market was valued at US$ 137.87 million in 2019 and is projected to reach US$ 297.62 million by 2027; it is expected to grow at a CAGR of 10.2% during the forecast period. The Middle East & Africa allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, drawbacks associated with the use of allergy immunotherapies, restricted healthcare spending and regulatory variations across regions is likely to hamper the growth of the market during the forecast period.
Key Market Segments
The Middle East and Africa Allergy immunotherapies market, based on treatment is segmented into Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). In 2019, the Subcutaneous Immunotherapy (SCIT) segment held the largest share of the market, however, the Sublingual Immunotherapy (SLIT) segment is expected to grow at the fastest rate during the forecast period. Based on Allergy Type, the Middle East and Africa allergy immunotherapies market was segmented into Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others. The Allergic Rhinitis segment held the highest share of the Allergy immunotherapies market in 2019. Moreover, the same segment is anticipated to witness growth at a significant rate during the forecast period.
Based on distribution channel, market is segmented into, hospital pharmacy, retail pharmacy and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market and the same pharmacy segment is expected to grow at the fastest rate during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Middle East & Africa allergy immunotherapies market included in the report are Celsion Corporation; World Allergy Organization (WAO); World Health Organization (WHO); Saudi Society of Allergy, Asthma and Immunology and Allergy Society of South Africa (ALLSA).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the Middle East & Africa allergy immunotherapy market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different Middle East & Africa allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East & Africa allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East & Africa immunotherapy market.
Middle East & Africa ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Company Profiles
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Allergy Immunotherapies Market – By Treatment
1.3.2 Middle East and Africa Allergy Immunotherapies Market – By Allergy Type
1.3.3 Middle East and Africa Allergy Immunotherapies Market – By Distribution Channel
1.3.4 Middle East and Africa Allergy Immunotherapies Market – By Geography
2. Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa (MEA) – PEST Analysis
4.3 Expert Opinion
5. Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysi
6. Allergy Immunotherapies Market – Middle East and Africa Analysis
6.1 Middle East and Africa Allergy Immunotherapies Market Revenue Forecast and Analysis
7. Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis and Forecasts To 2027 – Geographical Analysis
10.1 Middle East & Africa: Allergy immunotherapies market
10.1.1 Overview
10.1.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 South Africa: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East and Africa Allergy Immunotherapies Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AIMMUNE THERAPEUTICS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stallergenes Greer
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 HAL Allergy B.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson and Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Anergis
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DBV Technologies
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Allergy Therapeutics
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million
Table 8. UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. Allergy Immunotherapies Market Segmentation
Figure 2. Allergy Immunotherapies Market – By Geography
Figure 3. Middle East and Africa Allergy Immunotherapies Market Overview
Figure 4. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 5. Middle East and Africa Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Allergy Immunotherapies Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 10. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 11. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 13. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 14. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 15. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 16. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 18. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 19. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 22. Middle East & Africa: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 23. Middle East & Africa Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 24. Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 25. Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 26. UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 27. South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic on allergy immunotherapies market in Middle East and Africa
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
- Determine prospective investment areas based on a detailed trend analysis of the Middle East & Africa allergy immunotherapy market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different Middle East & Africa allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East & Africa allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East & Africa immunotherapy market.